Open access
Jul 2026
Heterogeneity in plasma p‐tau217 response and its association with cognitive trajectories under lecanemab treatment
Plasma phosphorylated tau 217 (p‐tau217) is a promising biomarker for monitoring treatment response in Alzheimer's disease (AD), but its longitudinal dynamics and clinical relevance remain unclear.
Sung-Hoon Kang, Yu Jeong Park, Seung-Yun Lee et al.
· Alzheimer's & Dementia · 0 citations